TrialThe Lancet. Respiratory medicine2019

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.

Richard T Davey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.